Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp154 | Cushing's | ECE2019

Pathway enrichment analysis in functioning and silent corticotroph pituitary adenomas reveals mechanisms to explain their distinct clinical behaviour

Olarescu Nicoleta Cristina , Normann Kjersti Ringvoll , Sundaram Arvind YM , Oystese Kristin Astrid Berland , Eieland Alexander , Lekva Tove , Bollerslev Jens

Background: Functioning (FCA) and silent corticotroph (SCA) pituitary adenomas act differently from a clinical perspective, despite both subtypes showing positive ACTH staining by immunohistochemistry. They are challenging to treat, the former due to functional ACTH production and consequently hypercortisolemia leading to Cushing disease, whereas the latter due to invasive and recurrent behaviour. Moreover, the molecular mechanisms behind their distinct behaviour are not clear...

ea0056p783 | Pituitary - Basic | ECE2018

Corticotroph pituitary adenomas: the functioning vs the silent: a gene expression study comparing differentially expressed genes in the regulation of POMC

Normann Kjersti Ringvoll , Sundaram Arvind , Oystese Kristin Astrid Berland , Lekva Tove , Eieland Alexander , Bollerslev Jens , Olarescu Nicoleta Cristina

Background: The exact mechanism behind the hypersecretion of ACTH and lack of negative cortisol feedback on POMC regulation in functional corticotroph adenomas (FCA) is unknown. Silent corticotroph adenomas (SCA) express, but do not secrete functional ACTH and have lower POMC expression. Using RT-qPCR and immunohistochemistry, previous studies have identified some POMC-transcription factors, regulators and processing enzymes to be differentially expressed between FCA and SCA. ...